Generic Manufacturers Can Make BIG Changes with Blockchain Technology

Corey Greco
Corey Greco

Published: 14.01.2023.

Biochemistry

Volume 6, Issue 1 (2023)

https://doi.org/10.30953/bhty.v6.254

Abstract

Blockchain technology has surfaced in the generic pharma arena addressing challenges associated with Contract Management, GPO interactions, and Chargeback adjudication. Manufacturers are now burdened with reducing overhead costs that impact the cost of each unit to get medication to patients safely, effectively, and efficiently. Blockchain technology can be used to enhance efficiencies in how partners interact including inventory management, sales data reporting, chargeback validations and rebate accruals.

Keywords

Citation

Copyright

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles